Loading...
TrendSpott

TrendSpott

TrendSpott
 
 
Haemonetics Corporat
82.75
+3.24%
 
Recommendation
HAE Haemonetics Corporat
  Login
 
 
Last Price
 
Change
 
82.75
 
+3.24%
 
 

 
Sentiment
 
  Login to display
 
 

80.44

73.6

83.12

57.66

 
 
1m
3m
6m
1y
 

Summary

  Login to display Haemonetics Corporat (HAE) recommendation from the last 90 days from financial news and social media.
 

Risk Analysis

Risk Analysis

 Enter oversold territory

Risk Analysis

 Investors losing their confidence

 
 

Risk Level

 
TrendSpott
 

Haemonetics Corporat (HAE) has Moderate Risk Level

Click here to check what is your level of risk

 

Analysts Opinion

Click on the category for more information
 
 
Earnings ×
 

Earnings

4.00
 

TrendSpott

 Above analyst estimates

 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

2.50
 

TrendSpott

 Enter oversold territory

 
Activity ×
 

Activity

3.50
 

TrendSpott

 Investors losing their confidence

 
Future ×
 

Future

4.00
 
 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
58%
NA
0%
100%
 
On Track
On Track
On Track
 

Street Opinion 

Street view is bullish and have positive views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
58%
25%
Positive
Negative
7 out of 12
events present
3 out of 12
events present
 

 
Events Calendar
Click for more information
 
February
S
M
T
W
T
F
S
March
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Strong Earnings
2 Month Ago
80.41
-3.00%
 
Investors Selling
2 Month Ago
87.79
+0.76%
 
Investors Activity
3 Month Ago
82.94
+9.85%
 
Top Headlines

haemonetics is now oversold (hae). legendary investor warren buffett advises to be fearful when others are greedy and be greedy when others are fearful. one way we can try to measure the level of fear in a given stock is through a technical

Fri Mar 10, 2023

Momentum

notable two hundred day moving average cross - hae. in trading on friday shares of haemonetics corp. (symbol: hae) crossed below their 200 day moving average of $75.69 changing hands as low as $75.59 per share. haemonetics corp. shares are

Fri Mar 10, 2023

Momentum

here is why growth investors should buy haemonetics (hae) now. growth stocks are attractive to many investors as above-average financial growth helps these stocks easily grab the markets attention and produce exceptional returns. but f

Thu Mar 9, 2023

Potential

haemonetics (hae) autotransfusion system gets 510(k) clearance. haemonetics hae recently gained fda&rsquo.s 510(k) clearance for its next-generation intelligent control software for cell saver elite autotransfusion system. the approval

Fri Mar 3, 2023

Activity

haemonetics (hae) q3 earnings beat estimates margins down. haemonetics corporation hae delivered adjusted earnings per share (eps) of 85 cents for the third quarter of fiscal 2023 reflecting growth of 1.2% year over year. the bottom li

Thu Feb 9, 2023

Earnings

haemonetics (hae) q3 earnings and revenues surpass estimates. haemonetics (hae) came out with quarterly earnings of $0.85 per share beating the zacks consensus estimate of $0.79 per share. this compares to earnings of $0.84 per share a

Tue Feb 7, 2023

Earnings

top-notch medical stocks incyte haemonetics beat — and shares crumbled.

Tue Feb 7, 2023

Momentum

wellington management group llp cuts stake in haemonetics (hae). fintel reports that wellington management group llp has filed a 13g/a form with the sec disclosing ownership of 4.03mm

Mon Feb 6, 2023

Activity

haemonetics (hae) presents at 41st annual j.p. morgan healthcare conference - slideshow.

Wed Jan 11, 2023

Activity

 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss
 

Receive our daily HAE alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
TrendSpott

TrendSpott

Get the pulse of the market

 
TrendSpott

TrendSpott

HAE Haemonetics Corporat

Last Price
82.75
Change
+3.24%
Recommendation
  Login to display
 

Summary

  Login to display Haemonetics Corporat (HAE) recommendation from the last 90 days from financial news and social media.

 
 
80.44
73.6
83.12
57.66
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Risk Analysis

Risk Analysis

 Enter oversold territory

Risk Analysis

 Investors losing their confidence

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
0%
100%
On Track
On Track
On Track
 
58%
25%
Positive
Negative
7 out of 12
events present
3 out of 12
events present
 

Street Opinion

Street view is bullish and have positive views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 
Earnings ×
 

Earnings

4.00
 

TrendSpott

 Above analyst estimates

 
 
Rating ×
 

Rating

NA
 
 
Momentum ×
 

Momentum

2.50
 

TrendSpott

 Enter oversold territory

 
Activity ×
 

Activity

3.50
 

TrendSpott

 Investors losing their confidence

 
Future ×
 

Future

4.00
 
 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
TrendSpott
 

Haemonetics Corporat (HAE) has Moderate Risk Level.  Click here to check what is your level of risk

 
 
 

Events Calendar

Hover for information

 
February
 
S
M
T
W
T
F
S
 
March
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change
 
Strong Earnings
2 Month Ago
80.41
-3.00%
 
Investors Selling
2 Month Ago
87.79
+0.76%
 
Investors Activity
3 Month Ago
82.94
+9.85%
 
 
 
TrendSpott

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

TrendSpott on Twitter TrendSpott on YouTube TrendSpott on stocktwits TrendSpott Rss

 

Receive our daily HAE Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by TrendSpott including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines